project id: TCGA-MESO; case submitter id: TCGA-SC-AA5Z; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.78; rna integrity number: 8.5; age at index: 54; days to birth: -19746; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 19746; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 664.0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 231; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-SC-AA5Z-01A-21; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 6.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;